HEPATIC ISCHAEMIA side effect
What is HEPATIC ISCHAEMIA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
HEPATIC ISCHAEMIA and Recently Reported Side Effects
HEPATIC ISCHAEMIA and 15 most Active Side Effect polls
HEPATIC ISCHAEMIA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Thymoglobulin Side Effects Report #5402238-3
Physician from UNITED STATES reported THYMOGLOBULIN problem on Nov 07, 2006. Male patient, 50 years of age, weighting 212.5 lb, was diagnosed with liver transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic ischaemia, kidney transplant rejection, liver injury, liver transplant rejection, . THYMOGLOBULIN dosage: 135 MG ONCE; IV. During the same period patient was treated with FLUCONAZOLE, GANCICLOVIR. Patient was hospitalized. Patient recovered.
Thymoglobulin Side Effects Report #5402238-3
THYMOGLOBULIN problem was reported by a Physician from UNITED STATES on Nov 07, 2006. Male patient, 50 years of age, weighting 212.5 lb, was diagnosed with liver transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic ischaemia, kidney transplant rejection, liver injury, liver transplant rejection, . THYMOGLOBULIN dosage: 135 MG ONCE; IV. During the same period patient was treated with FLUCONAZOLE, GANCICLOVIR. Patient was hospitalized. Patient recovered.
Ambisome Side Effects Report #5649038-7
Health Professional from FRANCE reported AMBISOME problem on Feb 14, 2008. Female patient, 50 years of age, was diagnosed with mucormycosis and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: cerebral ischaemia, hepatic infarction, hepatic ischaemia, hepatic necrosis, pseudomonas infection, renal failure, venous thrombosis, . AMBISOME dosage: 400 MG, UID/QD, IV NOS; 800 MG, UID/QD, IV NOS; 250 MG, UID/QD, IV NOS. During the same period patient was treated with IMIPENEM, CEFTAZIDIME PENTAHYDRATE, COLIMYCINE, AZACTAM, CYCLOPHOSPHAMIDE, METHOTREXATE, VINDESINE. Patient died on 01/29/2008.
Prograf Side Effects Report #5741259-8
PROGRAF problem was reported by a Physician from UNITED STATES on May 06, 2008. Male patient, 47 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, headache, hepatic ischaemia, multi-organ failure, pyrexia, transplant rejection, . PROGRAF dosage: 0.5 MG, UID/QD, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, SIROLIMUS, PREDNISOLONE ACETATE, DIFLUCAN, ROBAXIN, URSODIOL, AMBIEN, PROTONIX. Patient was hospitalized. Patient died on 08/19/2006.
Byetta Side Effects Report #5354153-1
Physician from UNITED STATES reported BYETTA problem on May 30, 2007. Female patient, 66 years of age, was diagnosed with diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: cholecystectomy, gastrointestinal ischaemia, hepatic ischaemia, metabolic acidosis, pancreatic pseudocyst, pancreatitis acute, . BYETTA dosage: unknown. Patient was hospitalized. Patient died on 05/19/2007.